MENU
APR 21, 2021 7:30 AM PDT

Panel Presentation: Next-Generation Sequencing in the Global Response to the COVID-19 Pandemic

C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Director, Bioinformatics, Illumina
    Biography

      Mr. Allen has over 30 years of experience in the fields of bioinformatics and software development.  He is currently Director, Bioinformatics at Illumina, Inc and is the software lead for several cloud based analysis products supporting oncology, genetic disease, and microbiology related studies using whole genome sequencing, targeted sequencing, RNASeq, bisulfite sequencing, and/or metagenomics types of library preps.  Most recently, he has led the teams for several COVID related data analysis products.  Prior to Illumina, Mr. Allen also worked in a variety of software and data analysis roles for companies such as IBM, AT&T, Oracle, and Neurocrine Biosciences.  Mr. Allen received his degrees from the University of Michigan in Ann Arbor, MI, the University of Texas in Austin, TX, and the University of San Diego in La Jolla, CA.

    • Associate Director, Product Management Infectious Disease & Microbiology, Illumina
      Biography

        The overall interest of Dr. Oberholzer is to translate novel research findings and emerging technologies into next-generation research tools, in-vitro diagnostic, and therapeutic products, to advance Science, and to improve human health. Dr. Michael Oberholzer is currently an Associate Director for Product Management at Illumina and his group is managing Microbiology & Infectious Disease genomics applications. Before joining Illumina, he has managed fully automated molecular in-vitro diagnostic test devices as well as with serological point-of-care tests for infectious diseases. Dr. Oberholzer received his PhD in Microbiology from the University of Bern Switzerland, where he identified and validated novel drug targets for Neglected Tropical Diseases. During his postdoctoral research at the Salk Institute for Biological Studies and at the University of California Los Angeles, Dr. Oberholzer worked on cell size homeostasis and cell cycle control as well as on host-pathogen interactions in parasitic protozoa using wide range of omics-based approaches.


      Abstract

      The SARS-CoV-2 pandemic is challenging our health care systems and will have a profound, long term impact on our society. The need for an immediate and concerted global genomic surveillance system to monitor the emergence of new variants is essential to support Public Health response efforts and vaccine deployment strategies. Genomic surveillance using Next-Generation Sequencing combined with global databases have enabled effective identification and tracking of emerging SARS-CoV-2 variants of concern at unprecedented scale. In this session, we will discuss Illumina’s comprehensive SARS-CoV-2 workflows and data analysis solutions for diagnostics and surveillance of SARS-CoV-2 and for detecting respiratory co-infections and antimicrobial resistance.

      Learning Objectives:

      1. Explain the genomic variability of SARS-CoV-2 and the relevance for virus epidemiology, diagnostics, and vaccines

      2. Define the unique role of Next-Generation Sequencing in the COVID-19 response

      3. Explain Next-Generation Sequencing workflows and software tools for COVID-19 diagnostic and surveillance


      Show Resources
      You May Also Like
      MAY 11, 2021 10:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      MAY 11, 2021 10:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
      OCT 29, 2020 6:00 AM PDT
      C.E. CREDITS
      OCT 29, 2020 6:00 AM PDT
      Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
      NOV 16, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 16, 2020 8:00 AM PST
      Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
      NOV 10, 2020 7:00 AM PST
      C.E. CREDITS
      NOV 10, 2020 7:00 AM PST
      DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
      NOV 18, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      FEB 24, 2021 10:00 AM PST
      C.E. CREDITS
      FEB 24, 2021 10:00 AM PST
      DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
      Loading Comments...
      Show Resources
      Attendees
      • See more